LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, CaliforniaCokey NguyenSVP and Chief Scientific Officer at Atara Biotherapeutics Inc
Profile
Dr. Cokey Nguyen serves as Senior Vice President, Chief Scientific Officer at Atara, where he is focused on leading the development of next-generation allogeneic cell therapies for cancer and autoimmune diseases. With significant experience in research and development of cell therapies, as well as oncology drug discovery and development in biotech, Dr. Nguyen holds numerous patents for iPSC and immune effector cells and has been published in various peer-reviewed journals. He received his undergraduate degree in biology from Harvard College and Ph.D. in Immunology from Washington University in St. Louis.
Agenda Sessions
Keynote: A First-In-Kind, Allogeneic EBV-Targeted T-Cell Immunotherapy Approach to Treating Multiple Sclerosis
, 9:15amView Session